Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Mueller Water Products
MWA
$4.04B
| $2.94M | ﹤0.01% |
204,102
-72,488
| -26% | -$1.09M |
|
2102
E.W. Scripps
SSP
$258M
| $2.94M | ﹤0.01% |
151,877
+20,069
| +15% | +$388K |
|
|
PMT
2103
PennyMac Mortgage Investment
PMT
$823M
| $2.94M | ﹤0.01% |
169,517
+41,289
| +32% | +$782K |
|
2104
Ciena
CIEN
$55.3B
| $2.93M | ﹤0.01% |
38,040
-142,098
| -79% | -$8.77M |
|
2105
MYR Group
MYRG
$5.26B
| $2.93M | ﹤0.01% |
26,464
+8,727
| +49% | +$947K |
|
2106
Jack in the Box
JACK
$324M
| $2.92M | ﹤0.01% |
33,368
+12,338
| +59% | +$1.15M |
|
2107
Lindsay Corp
LNN
$1.15B
| $2.91M | ﹤0.01% |
19,135
+743
| +4% | +$113K |
|
2108
Super Micro Computer
SMCI
$18.5B
| $2.9M | ﹤0.01% |
660,920
+199,780
| +43% | +$810K |
|
|
NAGE
2109
Niagen Bioscience
NAGE
$281M
| $2.9M | ﹤0.01% |
776,301
-180,440
| -19% | -$974K |
|
|
XHR
2110
Xenia Hotels & Resorts
XHR
$1.89B
| $2.9M | ﹤0.01% |
160,270
-24,713
| -13% | -$436K |
|
2111
Skywest
SKYW
$4.42B
| $2.9M | ﹤0.01% |
73,800
+22,341
| +43% | +$999K |
|
|
FFWM
2112
DELISTED
First Foundation Inc
FFWM
| $2.9M | ﹤0.01% |
116,578
+19,595
| +20% | +$522K |
|
2113
Kilroy Realty
KRC
$4.54B
| $2.9M | ﹤0.01% |
43,571
-68,583
| -61% | -$4.68M |
|
|
HEP
2114
DELISTED
Holly Energy Partners, L.P.
HEP
| $2.89M | ﹤0.01% |
175,531
-9,165
| -5% | -$163K |
|
2115
FB Financial Corp
FBK
$3.05B
| $2.89M | ﹤0.01% |
66,001
+17,179
| +35% | +$770K |
|
2116
iShares Russell 2000 Growth ETF
IWO
$14.6B
| $2.89M | ﹤0.01% |
9,861
-28,731
| -74% | -$8.66M |
|
2117
ARK Genomic Revolution ETF
ARKG
$1.6B
| $2.89M | ﹤0.01% |
47,151
+37,410
| +384% | +$2.59M |
|
2118
Bausch Health
BHC
$2.62B
| $2.89M | ﹤0.01% |
104,568
-20,255
| -16% | -$542K |
|
2119
Fulgent Genetics
FLGT
$500M
| $2.88M | ﹤0.01% |
28,680
+8,393
| +41% | +$738K |
|
2120
AXIS Capital
AXS
$7.72B
| $2.88M | ﹤0.01% |
52,921
-19,327
| -27% | -$1,000K |
|
2121
Westamerica Bancorp
WABC
$1.39B
| $2.88M | ﹤0.01% |
49,928
+15,175
| +44% | +$855K |
|
|
LBAI
2122
DELISTED
Lakeland Bancorp Inc
LBAI
| $2.88M | ﹤0.01% |
151,660
+20,744
| +16% | +$381K |
|
|
B
2123
DELISTED
Barnes Group Inc.
B
| $2.88M | ﹤0.01% |
61,762
+17,187
| +39% | +$760K |
|
2124
Independent Bank Corp
IBCP
$793M
| $2.88M | ﹤0.01% |
120,472
+18,368
| +18% | +$420K |
|
2125
Granite Construction
GVA
$5.43B
| $2.87M | ﹤0.01% |
74,208
+6,679
| +10% | +$265K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.